Dabigatran discontinuation in "real-world" practice among Chinese population

被引：0
|
作者：
Ho, M. H. [1 ]
Cheung, E. [1 ]
Ho, C. W. [1 ]
Tse, H. F. [1 ]
Siu, C. W. [1 ]
机构：
[1] Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
来源：
EUROPEAN HEART JOURNAL | 2014年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P6232
引用
收藏
页码：1104 / 1104
页数：1
相关论文
共 50 条
  • [41] Discontinuation of biologic DMARDs in a real-world population of patients with rheumatoid arthritis in remission: outcome and risk factors
    Arnold, Simone
    Jaeger, Veronika K.
    Scherer, Almut
    Ciurea, Adrian
    Walker, Ulrich A.
    Kyburz, Diego
    RHEUMATOLOGY, 2022, 61 (01) : 131 - 138
  • [42] Idarucizumab for Reversal of Dabigatran: Single-Center Real-World Experience
    Sheikh-Taha, Marwan
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2019, 19 (01) : 59 - 64
  • [43] Effect of plasma homocysteine on cardiometabolic multimorbidity among Chinese adults: a population-based and real-world evidence study
    Li, Ling
    Wang, Jia
    Li, Jing
    Li, Minqi
    Wang, Jie
    Long, Tianyao
    Zhengliu, Yangyi
    Tan, Xuan
    Peng, Yiwei
    Hong, Xiuqin
    FRONTIERS IN NUTRITION, 2024, 11
  • [44] Treatment Discontinuation, Adherence, and Real-World Effectiveness Among Patients Treated with Ledipasvir/Sofosbuvir in the United States
    Amy Puenpatom
    Michael Hull
    Jeffrey McPheeters
    Kay Schwebke
    Infectious Diseases and Therapy, 2017, 6 : 423 - 433
  • [45] Treatment Discontinuation, Adherence, and Real-World Effectiveness Among Patients Treated with Ledipasvir/Sofosbuvir in the United States
    Puenpatom, Amy
    Hull, Michael
    McPheeters, Jeffrey
    Schwebke, Kay
    INFECTIOUS DISEASES AND THERAPY, 2017, 6 (03) : 423 - 433
  • [46] phase IV study to evaluate the safety of fruquintinib in Chinese real-world clinical practice
    Li, Jin
    Wang, Zhi-Qiang
    Zhong, Haijun
    He, Yifu
    Zhang, Chen
    Niu, Zuoxing
    Yang, Shujun
    Zhang, Tao
    Zhu, Liangjun
    Shu, Yongqian
    Peng, Jianjun
    Song, Yan
    Li, Jian
    Yuan, Ying
    Zhang, Haibo
    Yu, Gengsheng
    Hua, Yun-Qi
    Xiao, Jianjun
    Shi, Michael
    Su, Weiguo
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [47] TREATMENT PARADIGMS IN REAL-WORLD PRACTICE: BIOLOGIC AGENT USE PRIOR TO AND AFTER DISCONTINUATION OF ABATACEPT IN THE ACTION STUDY
    Alten, R.
    Lorenz, H-M.
    Mariette, X.
    Nuesslein, H.
    Galeazzi, M.
    Navarro, F.
    Chartier, M.
    Elbez, Y.
    Rauch, C.
    Le Bars, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1141 - 1142
  • [48] Persistence of Dabigatran Versus Warfarin Therapy in Patients with Non-valvular Atrial Fibrillation in the Real-world Clinical Practice
    Lau, Wallis C. Y.
    Chan, Esther W.
    Wong, Ian C. K.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 382 - 382
  • [49] Association of statin use and the risk of recurrent pulmonary embolism in real-world Chinese population
    Wang, Lu
    Shu, Tingting
    Wang, Wuwan
    Chen, Huaqiao
    Feng, Panpan
    Xiang, Rui
    Huang, Wei
    PULMONARY CIRCULATION, 2021, 11 (03)
  • [50] A Real-World Experience on a Chinese Population of Patients With Unresectable Hepatocellular Carcinoma Treated With Nivolumab
    Lee, Shou-Wu
    Yang, Sheng-Shun
    Lee, Teng-Yu
    GASTROENTEROLOGY RESEARCH, 2024, 17 (01) : 15 - 22
12345